Jayson Dallas
2017
In 2017, Jayson Dallas earned a total compensation of $2.8M as Chief Commercial Officer and Executive Vice President at Ultragenyx Pharmaceutical, a 25% increase compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $180,389 |
| Option Awards | $1,652,013 |
| Salary | $447,517 |
| Stock Awards | $468,443 |
| Other | $36,345 |
| Total | $2,834,707 |
Dallas received $1.7M in option awards, accounting for 58% of the total pay in 2017.
Dallas also received $50K in bonus, $180.4K in non-equity incentive plan, $447.5K in salary, $468.4K in stock awards and $36.3K in other compensation.
Rankings
In 2017, Jayson Dallas' compensation ranked 3,854th out of 14,666 executives tracked by ExecPay. In other words, Dallas earned more than 73.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,854 out of 14,666 | 74th |
Division Manufacturing | 1,347 out of 5,772 | 77th |
Major group Chemicals And Allied Products | 381 out of 2,075 | 82nd |
Industry group Drugs | 295 out of 1,731 | 83rd |
Industry Pharmaceutical Preparations | 235 out of 1,333 | 82nd |
Source: SEC filing on April 27, 2018.
Dallas' colleagues
We found five more compensation records of executives who worked with Jayson Dallas at Ultragenyx Pharmaceutical in 2017.
2017
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2017
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2017
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officers and Executive Vice President
2017
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Officer and Executive Vice President of Translational Sciences
2017
Karah Parschauer
Ultragenyx Pharmaceutical